4-56011950-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_025009.5(CEP135):​c.2767G>A​(p.Glu923Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00189 in 1,576,822 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 2 hom. )

Consequence

CEP135
NM_025009.5 missense

Scores

4
7
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 7.08

Publications

5 publications found
Variant links:
Genes affected
CEP135 (HGNC:29086): (centrosomal protein 135) This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]
CEP135 Gene-Disease associations (from GenCC):
  • microcephaly 8, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01546675).
BP6
Variant 4-56011950-G-A is Benign according to our data. Variant chr4-56011950-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210679.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00156 (237/152282) while in subpopulation NFE AF = 0.00293 (199/68028). AF 95% confidence interval is 0.00259. There are 0 homozygotes in GnomAd4. There are 113 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_025009.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP135
NM_025009.5
MANE Select
c.2767G>Ap.Glu923Lys
missense
Exon 21 of 26NP_079285.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP135
ENST00000257287.5
TSL:1 MANE Select
c.2767G>Ap.Glu923Lys
missense
Exon 21 of 26ENSP00000257287.3
CEP135
ENST00000506202.1
TSL:1
n.2717G>A
non_coding_transcript_exon
Exon 14 of 19
CEP135
ENST00000706801.1
n.832G>A
non_coding_transcript_exon
Exon 5 of 10

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
237
AN:
152164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00292
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00147
AC:
325
AN:
221644
AF XY:
0.00156
show subpopulations
Gnomad AFR exome
AF:
0.000274
Gnomad AMR exome
AF:
0.000593
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00155
Gnomad NFE exome
AF:
0.00246
Gnomad OTH exome
AF:
0.00173
GnomAD4 exome
AF:
0.00193
AC:
2746
AN:
1424540
Hom.:
2
Cov.:
31
AF XY:
0.00195
AC XY:
1383
AN XY:
708092
show subpopulations
African (AFR)
AF:
0.000287
AC:
9
AN:
31354
American (AMR)
AF:
0.000688
AC:
26
AN:
37774
Ashkenazi Jewish (ASJ)
AF:
0.000161
AC:
4
AN:
24858
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38040
South Asian (SAS)
AF:
0.000390
AC:
31
AN:
79388
European-Finnish (FIN)
AF:
0.00171
AC:
90
AN:
52694
Middle Eastern (MID)
AF:
0.000893
AC:
5
AN:
5598
European-Non Finnish (NFE)
AF:
0.00226
AC:
2482
AN:
1096136
Other (OTH)
AF:
0.00169
AC:
99
AN:
58698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
120
239
359
478
598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00156
AC:
237
AN:
152282
Hom.:
0
Cov.:
32
AF XY:
0.00152
AC XY:
113
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41550
American (AMR)
AF:
0.000654
AC:
10
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00293
AC:
199
AN:
68028
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
3
Bravo
AF:
0.00149
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00174
AC:
211
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 04, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEP135-related disorder Benign:1
Apr 20, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.53
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.30
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.17
T
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
7.1
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.22
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.028
D
Polyphen
1.0
D
Vest4
0.26
MVP
0.75
MPC
0.38
ClinPred
0.046
T
GERP RS
5.7
Varity_R
0.69
gMVP
0.32
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145959811; hg19: chr4-56878116; COSMIC: COSV106085302; API